| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |